NLRP3 and metabolic dysfunction-associated steatohepatitis: Correspondingly, a rich body of preclinical studies showed that Nlrp3 deficiency in mice protects against inflammatory pathology in models of gout, pseudogout, atherosclerosis, inflammatory arthritis, non‐alcoholic steatohepatitis (NASH), Alzheimer's disease (AD), and the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.46, 47, 48, 49, 50, 51, 52, 53, 54